Clinical Trial Update: Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety of an oral vinorelbine and capecitabine combination in metastatic breast cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Vinorelbine (oral) (Vinorelbine)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED